Leander, K., Dahl, M., Vikström, M., Möller, J., & Söderberg-Löfdal, K. CYP2D6-inhibiting drugs and risk of fall injury after newly initiated therapy with beta-blockers—a register-based case-crossover study. Nature Portfolio.
Chicago Style (17th ed.) CitationLeander, Karin, M.-L Dahl, M. Vikström, J. Möller, and K. Söderberg-Löfdal. CYP2D6-inhibiting Drugs and Risk of Fall Injury After Newly Initiated Therapy with Beta-blockers—a Register-based Case-crossover Study. Nature Portfolio.
MLA (9th ed.) CitationLeander, Karin, et al. CYP2D6-inhibiting Drugs and Risk of Fall Injury After Newly Initiated Therapy with Beta-blockers—a Register-based Case-crossover Study. Nature Portfolio.
Warning: These citations may not always be 100% accurate.